The Hormone Optimization Protocol Most Men Are Getting Half Right

You've been waking up exhausted, your gym progress has stalled despite consistent effort, and your libido has gone quiet in a way that feels unfamiliar. You get bloodwork done, and the number comes back at 380 ng/dL. Your doctor tells you that's "normal." Technically, it is — the standard reference range bottoms out around 300 ng/dL. But the clinical floor is not the same as optimal, and that gap is where most men's protocols fall apart before they even begin.

What "Optimized" Actually Means in Numbers

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy defines symptomatic hypogonadism as total testosterone below 300 ng/dL — but practitioners working in optimization contexts often target a functional range of 700–1,000 ng/dL for men seeking peak wellbeing, not simply disease-state correction. Free testosterone matters too, typically targeted at 15–25 pg/mL using sensitive assay methods, since it's the bioavailable fraction that actually enters cells.

Estradiol (E2) is the number most men skip, and it's the one that causes the most trouble. On testosterone replacement, estradiol commonly rises via aromatisation. A working target for men on TRT is 20–40 pg/mL on a sensitive immunoassay. Go above 60 pg/mL for extended periods and you'll recognise the symptoms — water retention, moodiness, blunted libido — as problems wrongly attributed to the testosterone itself.

SHBG (sex hormone binding globulin) is the third rail. At 60–70 nmol/L, SHBG binds so much testosterone that even a 900 ng/dL total reading leaves free testosterone starved. At 15 nmol/L, the opposite problem: fast metabolism, uneven absorption, and instability between doses. The protocol that ignores SHBG is optimizing in the dark.

The Testosterone Delivery Problem

Intramuscular injections of testosterone cypionate remain the most cost-effective delivery format in 2026 — typically $30–$80/month for the medication itself through online hormone programs that include physician oversight. Weekly 100 mg injections produce peak-and-trough swings that many men find destabilising — high energy on days 3–4, flat on days 6–7. Splitting the same dose twice weekly (50 mg every 3.5 days) dramatically smooths the curve and is the standard approach at most evidence-oriented clinics.

Subcutaneous injections into abdominal fat are now equally common and produce slower, more stable absorption than IM in most men. They're also easier to self-administer, which matters for long-term adherence.

Topical gels work for men with SHBG in the mid-range who absorb predictably, but transfer risk to partners and variable skin absorption make them a second-tier choice for anyone serious about dialing in precise levels.

Growth Hormone Peptides: The Underused Layer

TRT addresses androgens but doesn't touch the GH-IGF-1 axis, which declines measurably after age 30. Peptide secretagogues are the most practical tool available for that gap.

Ipamorelin at 200–300 mcg subcutaneously before sleep is the entry-level standard — it triggers a GH pulse without meaningfully raising cortisol or prolactin the way older peptides such as GHRP-2 did. Most practitioners run it in 12–16 week cycles. IGF-1 is the tracking biomarker; a reasonable target for an optimized adult male is 200–300 ng/mL, up from levels that commonly fall to 120–150 ng/mL in men in their 40s and 50s without intervention.

Tesamorelin is the more potent option — FDA-approved in its branded form for HIV-associated lipodystrophy, and used off-label in optimization contexts at doses of 1–2 mg per night. A 2010 Falutz et al. trial found it reduced visceral adipose tissue by approximately 18% over 26 weeks in its approved population. That visceral fat reduction mechanism is why it appears in body-composition protocols alongside TRT, not just as a standalone.

Running a growth hormone peptide alongside TRT without tracking IGF-1 every 8–12 weeks is sloppy. The number tells you whether the dose is working; clinical feel alone is unreliable.

What the Protocol Misses (And Why It Matters)

Sleep and cortisol are the variables that make or break everything else. A man running a technically sound TRT and peptide protocol who sleeps six hours and carries chronically elevated cortisol will blunt his own results. Cortisol and testosterone operate in opposition; a 2011 Leproult and Van Cauter study published in JAMA found that restricting sleep to 5 hours per night for one week reduced total testosterone by 10–15% in healthy young men. No protocol compensates for that.

Thyroid is the other common miss. Subclinical hypothyroidism — TSH above 2.5 mIU/L with symptoms — is routinely dismissed on standard panels, but it drives fatigue, fat accumulation, and mood flattening that mirror low-T presentation exactly. Running a complete thyroid panel (TSH, Free T3, Free T4, reverse T3) before attributing everything to androgens is standard practice at competent hormone optimization clinics.

Choosing the Right Provider Setup

The difference between a telehealth provider who refills prescriptions and a clinic that runs an actual protocol is biomarker frequency and dose adjustment. A functional protocol should include comprehensive bloodwork at baseline, then at 6–8 weeks post-initiation, then every 12–16 weeks for ongoing management. That means at minimum: total and free testosterone, estradiol (sensitive assay), SHBG, LH, FSH, IGF-1, CBC, and PSA for men over 40.

System Labs is one platform that bundles lab draws with clinical review rather than treating them as separate transactions — the practical model for men who want the protocol managed cohesively rather than assembled from disconnected pieces. For men comparing multiple options before committing, find a hormone clinic filters by goal, making it easier to match provider focus to what you're actually trying to achieve.

The Specific Takeaway

If your current protocol doesn't include estradiol tracking, SHBG measurement, and IGF-1 follow-up, you're running an incomplete system. Start there. Fix the monitoring before you adjust the doses. The men who plateau on TRT are almost always dealing with an unmanaged variable — elevated SHBG, high estradiol, or suppressed thyroid — that quarterly labs would have caught within the first 90 days.

---

Peptide Clinic Finder is a comparison platform. The author may receive compensation if you sign up through links on our partner pages.

---